NAFLD and Cardiometabolic Risk Factors: The Liver Fibrosis Trajectory Through the Lens of Biological Interactions

被引：3
|
作者：
Pirola, Carlos J. [1 ,2 ]
Sookoian, Silvia [1 ,3 ]
机构：
[1] Univ Buenos Aires, Fac Med, Inst Invest Med A Lanari, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn CONICET, Dept Genet & Biol Mol Enfermedades Complejas, Inst Invest Med IDIM, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn CONICET, Dept Hepatol Clin & Mol, Inst Invest Med IDIM, Buenos Aires, DF, Argentina
来源：
HEPATOLOGY | 2021年 / 73卷 / 02期
关键词：
D O I：
10.1002/hep.31672
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：479 / 482
页数：4
相关论文
共 50 条
  • [41] Risk of severe fibrosis is associated with age at menopause in nonalcoholic fatty liver disease (NAFLD)
    Klair, Jagpal S.
    Yang, Ju Dong
    Abdelmalek, Manal F.
    Guy, Cynthia D.
    Gill, Ryan M.
    Yates, Katherine P.
    Unalp-Arida, Aynur
    Lavine, Joel E.
    Clark, Jeanne M.
    Diehl, Anna Mae
    Suzuki, Ayako
    HEPATOLOGY, 2014, 60 : 621A - 621A
  • [42] DEGREE OF FIBROSIS IN LIVER BIOPSY RESULTS OF NAFLD PATIENTS SIGNIFICANTLY CHANGES PATIENT'S WEIGHT LOSS TRAJECTORY
    Tian, Ye
    Xiao, Karen
    Chen, Chixiang
    Tessiatore, Kristen
    Prenner, Stacey
    Weinberg, Ethan M.
    HEPATOLOGY, 2021, 74 : 1002A - 1003A
  • [43] LIVER ENZYMES AND CARDIOMETABOLIC RISK FACTORS IN EUROPEAN ADOLESCENTS; THE HELENA STUDY
    Labayen, I.
    Ruiz, J. R.
    Ortega, F. B.
    Rodriguez, G.
    Davis, C. L.
    Gonzalez-Gross, M.
    Breidenassel, C.
    de Henauw, S.
    Marcos, A.
    Widhalm, K.
    Dallongeville, J.
    Molnar, D.
    Palacios, G.
    Gottrand, F.
    Moreno, L. A.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 1169 - 1170
  • [44] Association of Inflammatory and Liver Markers with Cardiometabolic Risk Factors in Patients with Depression
    Nebhinani, Naresh
    Sharma, Praveen
    Pareek, Vrinda
    Suthar, Navratan
    Jakhotia, Shobhan
    Gehlot, Mukesh
    Purohit, Purvi
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2019, 34 (02) : 219 - 224
  • [45] Overweight, central obesity, and cardiometabolic risk factors in pediatric liver transplantation
    Dagher, Marc
    Ng, Vicky L.
    Carpenter, Andrea
    Rankin, Stephanie
    De Angelis, Maria
    Avitzur, Yaron
    Mouzaki, Marialena
    PEDIATRIC TRANSPLANTATION, 2015, 19 (02) : 175 - 181
  • [46] Association of Inflammatory and Liver Markers with Cardiometabolic Risk Factors in Patients with Depression
    Naresh Nebhinani
    Praveen Sharma
    Vrinda Pareek
    Navratan Suthar
    Shobhan Jakhotia
    Mukesh Gehlot
    Purvi Purohit
    Indian Journal of Clinical Biochemistry, 2019, 34 : 219 - 224
  • [47] Risk Factors for Hepatic Steatosis in Cystic Fibrosis Are Distinct from Risk Factors for Cystic Fibrosis Liver Disease
    Ayoub, Fares
    Lascano, Jorge
    Morelli, Giuseppe
    HEPATOLOGY, 2017, 66 : 663A - 664A
  • [48] The evolution of early cellular systems viewed through the lens of biological interactions
    Poole, Anthony M.
    Lundin, Daniel
    Rytkoenen, Kalle T.
    FRONTIERS IN MICROBIOLOGY, 2015, 6
  • [49] Liver disease in Cystic Fibrosis - prevalence and risk factors
    Schibli, S.
    Rose, J.
    Durie, P.
    Ellis, L.
    Tullis, E.
    Kovesi, T.
    Corey, M.
    SWISS MEDICAL WEEKLY, 2006, 136 : 14S - 14S
  • [50] YPrevalence and Risk Factors of NAFLD, High-Risk NASH, and Fibrosis Among Lean US Adults
    Kalligeros, Markos
    Vassilopoulos, Stephanos
    Vassilopoulos, Athanasios
    Shehadeh, Fadi
    Lazaridou, Ingrid
    Mylonakis, Eleftherios
    Promrat, Kittichai
    Wands, Jack R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1055 - S1056
12345